製品名称: | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9, 11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5, 12-dione |
CAS登録番号: | 23214-92-8 |
EINECS: | 245-495-6 |
シノニム: |
Adriamycin; Adriablastin; Doxil; Doxorubicinum; Adriblastin; Doxorubicine; Adriblastina; Myocet;(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9, 11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5, 12-dione; Rubex; |
分子構造: | |
分子式: | C27H29NO11 |
分子: | 543.51926 |
密度: | 1.61 g/cm3 |
沸点: | RELATIVE DENSITY |
融点: | 205℃ |
フラッシュポイント: | 443.8 °C |
屈折率: | 1.709 |
安全文: | Confirmed carcinogen with experimental carcinogenic, neoplastigenic, and tumorigenic data. Poison by intraperitoneal, subcutaneous, parenteral, and intravenous routes. Human systemic effects by intravenous route: cardiac myopathy including infarction, nausea or vomiting, and effects on the hair. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of NOx and HCl. |
ハザードシンボル: | UN NO. |